- Fund Type: ETF
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: U.S.
SPDR S&P Biotech ETF
+ Add to WatchlistXBI:US
109.7600 USD 1.0700 0.98%As of 20:04:02 ET on 05/21/2013.
Snapshot for SPDR S&P Biotech ETF (XBI)
| Open: | 108.8700 | High - Low: | 110.2200 - 108.5500 | Primary Exchange: | NYSE Arca |
|---|---|---|---|---|---|
| Volume: | 141,106 | 52-Week Range: | 77.0000 - 112.0899 | Beta vs SPSIBITR: | 1.0003 |
Fund Profile & Information for XBI
SPDR S&P Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to replicate the performance of the S&P Biotechnology Select Industry Index, an equal-weighed index. The Index tracks all the US common stocks listed on the NYSE, American Stock Exchange, NASDAQ National Market and NASDAQ Small Cap exchanges.
| Inception Date: | 2006-01-31 | Telephone: | 1-866-787-2257 |
|---|---|---|---|
| Managers: | JOHN A TUCKER | ||
| Web Site: | www.spdrs.com | ||
Fundamentals for XBI
| NAV | (on 2013-05-21) 109.7959 |
|---|---|
| Assets (M) | (on 2013-05-21) 889.3467 |
| Shares out (M) | 8.10 |
| Market Cap (M) | 889.06 |
| % Premium | -0.03 |
| Average 52-Week % Premium | -0.0155 |
| Fund Leveraged | N |
Dividends for XBI
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Quarter |
| Last Dividend Net | (on 2013-03-15) 0.0440 |
| Dividend Yield (ttm) | 0.16% |
Performance for XBI
| 1-Month | +2.65% | 1-Year | +38.49% |
|---|---|---|---|
| 3-Month | +13.92% | 3-Year | +26.96% |
| Year To Date | +23.69% | 5-Year | +13.69% |
| Expense Ratio | 0.35 |
Top Fund Holdings for XBI
Filing Date: 05/20/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| NPS Pharmaceuticals Inc | 2,267,779 | 31,998,362 | 3.637% |
| Aegerion Pharmaceuticals Inc | 504,545 | 30,328,200 | 3.447% |
| Regeneron Pharmaceuticals Inc | 107,662 | 28,384,010 | 3.226% |
| Theravance Inc | 750,556 | 27,778,078 | 3.157% |
| Vertex Pharmaceuticals Inc | 352,563 | 27,274,274 | 3.100% |
| Alkermes PLC | 815,251 | 25,305,391 | 2.876% |
| Myriad Genetics Inc | 740,900 | 24,494,154 | 2.784% |
| Biogen Idec Inc | 107,999 | 24,319,215 | 2.764% |
| Gilead Sciences Inc | 410,381 | 22,874,637 | 2.600% |
| Sarepta Therapeutics Inc | 611,869 | 22,718,696 | 2.582% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page